Terms: = Pancreatic cancer AND CNBP, P62633, 7555, ENSG00000169714, ZNF9, RNF163, DM2 AND Treatment
3 results:
1. Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment.
Pretta A; Ziranu P; Giampieri R; Donisi C; Cimbro E; Spanu D; Lai E; Pecci F; Balconi F; Lupi A; Pozzari M; Persano M; Murgia S; Pusceddu V; Puzzoni M; Berardi R; Scartozzi M
Dig Liver Dis; 2023 May; 55(5):655-660. PubMed ID: 36513569
[TBL] [Abstract] [Full Text] [Related]
2. Does the use of incretin-based medications increase the risk of cancer in patients with type-2 diabetes mellitus?
Karp I; Sivaswamy A; Booth C
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):489-499. PubMed ID: 30779266
[TBL] [Abstract] [Full Text] [Related]
3. Type 2 diabetes mellitus and pancreatic cancer.
McAuliffe JC; Christein JD
Surg Clin North Am; 2013 Jun; 93(3):619-27. PubMed ID: 23632148
[TBL] [Abstract] [Full Text] [Related]
